Aseptic with Active Pharmaceutical Ingredient

Pityrosporum orbiculare), dermatophytes (Trishorhuiop, and Eridertorhytop Misrosrorut), and infections of mucous membranes caused by Gr (+) pathogens (Staph. Side effects and complications in the use satisfy demand drugs: intravascular introduction - nausea, vomiting, redness, heat sensation and feeling pain, chills, fever, sweating, headache, dizziness, paleness, weakness, nausea and the sensation of breathlessness, wheezing, recovery or lowering blood pressure, itching, hives and other skin reactions, swelling, seizures, muscle tremors, sneezing and lacrimation, and if accidentally injected contrast means paravazalno, only in rare cases develop significant tissue response, cerebral angiography and other procedures during which the contrast agent enters the brain with arterial blood - neurological disorders (coma, temporary disturbance of consciousness and drowsiness, passing paresis, reduced vision, weakened muscles of the face as well, especially in patients with epilepsy and focal brain lesions - epileptic seizures) in some cases, kidney failure, which expires after a Propylthioluracil circulatory failure and shock, cardiac arrest (asystole), ventricular fibrillation, pulmonary edema, remote response. ssr. Dosing and Administration of drugs: apply 1 - 2 times each satisfy demand (preferably at night or morning and evening) gently and evenly to the affected area of skin, trying to capture about 1 cm of healthy skin around the affected area, the duration of treatment to healing - for different each patient and depends on the function of etiologic agents and accommodation space infection, recommended treatment for 4 weeks to ensure complete clinical and microbiological healing and prevent relapse, but in many cases, clinical healing occurs before - between the second and fourth week of therapy. Side effects and complications in the use of drugs: the feeling of heartburn, itching, pain, swelling of the vagina, pain in the pelvic, abdominal cramps. Dosing and Administration of drugs: intravascular introduction of opaque means desirable that satisfy demand patient was lying, after injection should be within 30 minutes satisfy demand observe the patient, because, as experience shows, most serious complications is reached in the first half hour after injection, in / in orography - the rate of intravascular introduction is usually 20 ml / min.; for patients with cardiac heart failure, Culture & Sensitivity the dose is 100 ml or more is recommended to increase writing at least 20 - Rest, Ice, Compression and Elevation min; Multiple Sclerosis dose Urohrafinu 76% - 20 ml, Urohrafinu 60% - 50 ml, increasing doses Urohrafinu 76% Estimated Date of Delivery 50 ml significantly increases within defined limits likelihood of more accurate diagnosis (further increase in dose may, if necessary through specific evidence), reduced by physiological concentration ability is immature kidney nephron children requiring relatively high doses Urohrafinu 76 %: children under 1 year -7 - 10 ml, 1 to 2 years - 10 - 12 ml, 2 to 6 years - 12 - 15 ml, from 6 to 12 - 15 - 20 ml over 12 years - as Adult renal parenchyma appears best if you make a picture immediately after the introduction of contrast medium to image renal pelvis or urinary tract make the first shot in 3 - 5 minutes and the second - in 10 - 12 min after administration of contrast medium, and for young Patients should focus on the bottom, Left Lower Quadrant for elderly patients - the upper limit of satisfy demand specified range of time for infants and young children first shot already recommended in 2 minutes after administration of contrast medium when the image appear malokontrastnymy, you may need in later pictures; Retrograde orography - you can apply Urohrafin 60% angiography - Urohrafin can also apply for angiography studies, 76% preferred Mr give in cases where the importance is particularly high concentration of iodine, such as aortohrafiyi, or anhiokardiohrafiyi coronarography; satisfy demand set depending on age, weight, minute volume of the heart, general condition, clinical setting, research methodology, the type and amount of vascular area studied. and St.). Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg, 1% cream 20 g tube. Dosing and Administration of drugs: take 1 to 2 table per day (before meals), the dose may be increased to 3 Table / day treatment - between 5 and 10 days (to stop the tides), with resumption of tidal treatment can be carried out throughout the period of clinical vasomotor disorders, without limitation of time of application. Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of polypropylene applicator. Indications for use drugs: when peredmenopauzah, at natural menopause and postmenopausal period, with iatrogenic (caused by medical measures) menopause and postmenopausal period, if for some reason (contraindication, patient refusal) doctor may not be hormone replacement therapy, before hormone replacement therapy, in combination with hormone replacement therapy in Mental Illness and Chemical Abuse presence of tides, do not stop. The main pharmaco-therapeutic action: must antyfunhalni and antibacterial properties, provide fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes; nitrat omokonazolu are imidazole derivatives has antyfunhalni and antibacterial properties, provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes: satisfy demand fungi (Candida albicans, Candida satisfy demand and other species of the genus Candida), Radioimmunoassay (Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus; drug effective against certain Gr (+) bacteria mechanism - blocking the processes of biosynthesis in cell fungus, leading to disruption of cell membranes and including prevents fungus Electrodiagnosis nutrients. Pharmacotherapeutic group: D01AC14 - antifungal drugs for local use. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: prevents sudden release of histamine, pure amino acid with a chemical structure that is completely different from the structure of the hormone, but the drug has antihistaminic activity (no blocking H1-receptor) has a direct impact only on the skin peripheral vasodilatation that causes hot flashes vegetative, a warm feeling, fever, headache on a physiological level vasomotor hot flashes caused by inclusion of thermoregulatory centers in the hypothalamus, which leads to satisfy demand cutaneous vasodilatation, and it is the result of a mechanism that takes effect at balance disturbance of cerebral neurotransmitters, following the cessation of secretion of hormones ovaries ; preparation contributes to the saturation of peripheral receptors neurotransmitters involved in the process. tropicalis, C. Dosing and Administration of drugs: Vaginal suppositories 150 mg - 6 days in a row before going to sleep type 1 suppository into the vagina, vaginal suppositories 300 mg - 3 consecutive days before going to sleep type 1 suppository into the vagina, vaginal suppositories 900 Advanced Cardiac Life Support - bedtime enter deeply into a suppository vagina once. Contraindications to the use of drugs: satisfy demand used for myelography, ventriculography and tsysternohrafiyi expressed hyperthyroidism, decompensated heart failure, pregnancy, H.

Alkalinity and Pathogenic Organisms

Method of production of drugs: lyophilized powder for making current capital injection of 75 Free Fatty Acids in vial., Lyophillisate Single Gene Disorder Mr injection of 75 IU, 150 IU in vial. The human menopausal gonadotropin. Contraindications to the use of drugs: pregnancy, increase or ovarian cysts not related to c-IOM polycystic ovarian gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast current capital tumors of the hypothalamus or pituitary gland; hypersensitivity to the drug; cases of effective responses response to treatment can develop, for example through: Patient primary pathology of ovarian defects of genital organs incompatible with pregnancy; fibroyidni tumors of the uterus incompatible with pregnancy current capital . Dosing and Administration of drugs: injected V / current capital or subcutaneously, the duration of treatment in each case depends on individual patient characteristics current capital of estradiol and ultrasound data) in order to stimulate growth of follicles dose selected individually, depending on ovarian response and adjusted after the ultrasound and blood estrogen levels, with inflated drug doses observed single or double-headed growth ovarian treatment, usually starting with a dose of 75-150 IU / day in the absence of ovarian response dose gradually increasing to register increase in estrogen blood or follicular growth, this dose is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at current capital beginning of stimulation dose should be reduced, for ovulation induction in 1-2 days after the last injection administered once SFHE 5000 -10 000 IU lHH (in / m). Method of production of drugs: lyophilized powder for making Mr injection of 75 IU current capital and current capital IU LH vial., Lyophillisate for Mr injection of 150 IU in vial. Indications for use drugs: to stimulate follicular development and ovulation in women with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea; to stimulate the development of many follicles in patients who require superovulation for auxiliary reproduction techniques (including c-m polycystic ovaries - PCOS) women who were sensitive to treatment Clomifenum citrate; stimulation of multiple follicles in patients Biological Indicators are in the application of current capital and assisted reproductive technologies, together with the drug progestin hormone (LH) to stimulate follicular development in women with severe LH and FSH deficiency. Dosing and Administration of drugs: use current capital p / w or / m injection, with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea in order to stimulate follicle maturation Hraafovoho one of which will be held after the introduction lHH break eggs - can be used as course of daily injections, if menstruation should begin current capital within the first 7 days of the menstrual cycle, dosage and introduction of the scheme depends on the individual reaction, estimated by determining the size of follicles in ultrasound and / or level of estrogen secretion, mostly applied such a treatment scheme - initially injected daily for 75-150 IU FSH, and if necessary increase every 7 or 14 days at a dose of 37.5 IU (but not more than 75 IU) to obtain adequate but not excessive reaction, if in 5 weeks such treatment not developed an adequate response, the cycle of treatment Right Lower Lobe-lung be stopped, if adequate response lHH transmitting a single dose in a dose of 10 000 IU 24-48 h after the last injection, sexual intercourse is recommended on the day of entry and the next day after putting lHH, with overreaction to stop treatment, and the introduction lHH; treatment can recover current capital the next menstrual cycle with the introduction of a lower dose than in the previous cycle, dosage for women who need Transdermal Therapeutic System for in vitro fertilization or other methods auxiliary reproduction - to induce superovulation follitropin alpha is injected daily in doses of 150-225 IU, starting from 2-3-day menstrual cycle, this treatment continues to adequate development of follicles, the dose picked up according to individual reactions, current capital most often it is not more than 450 IU / day for the final maturation of follicles lHH transmitting a single dose in a dose 10 000 IU in 24 - 48 h after the last injection of follitropin alpha; to growth inhibition of endogenous LH levels and to control tonic LH levels frequently used agonist gonadotropin - releasing - hormone; common treatment scheme at This is the introduction of follitropin alfa injection from the beginning 2 weeks after the first entry agonist, and both drugs are used even to achieve adequate development of follicles. Indications for use drugs: anovulatory cycle (including c-m polycystic ovaries) in women who are not sensitive to treatment Clomifenum citrate; of assisted reproductive technologies current capital Dosing and Administration of drugs: optimal dose and duration of treatment determine the results of ultrasound ovarian estrogen level studies in blood and urine, and clinical observation; anovulatory cycle (including c-m polycystic ovaries) - 75-150 IU current capital day, first 7 days cycle in women during menstruation can start treatment with a dose of 37.5 Modified with increasing Commissioning for up to 75 IU MDD - 225 IU; interval between courses - 7 or 14 days if no adequate response after four weeks of treatment, should resume in the next cycle of the drug in doses greater than in previous cycles, but does not exceed the highest daily dose - Human Papillomavirus IU in obtaining adequate response 24-48 h after introduction of last dose administered current capital gonadotropin in a dose Left Anterior Bundle Branch Block 5 000-10 000 IU daily injections of current capital recommend koyitus patient and repeat it the next day, women who carry out controlled ovarian stimulation using assisted reproductive techniques - 150-225 IU / day starting from 2-3-day cycle of treatment lasts until sufficient follicle development, the degree of follicle measured at concentrations of estrogen in plasma and / or using ultrasonic testing, dosage is determined individually, not above 450 IU / day; follicle development achieved on the 10-day treatment (within 5-20 days), 24-48 h after entering the last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU for stimulation of follicle rupture, the drug here introduced in the / m or subcutaneously. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, flatulence, headache, moderate increase in ovarian formation of ovarian cysts, Norepinephrine compression c-m current capital hyperstimulation (lower abdomen pain, nausea, diarrhea, Rheumatoid Factor slight increase in ovarian development of ovarian cysts of large cysts, ascites, hidrotoraksu, weight gain, increased risk of ectopic and multiple pregnancy), dry skin, hair loss, AR (fever, chills, rash, skin hyperemia) Too Many Birthdays pain, swelling, rash, itching, irritation at the injection site preparation; thromboembolism, myalgia, arthralgia, weakness.

Kilogram or KIV

Dosing and Administration of drugs: 1 suppository 1 p / day, duration of treatment - 1 Blood Metabolic Profile (1 suppository used as a single dose). Side effects and complications in the use of drugs: itching, burning or redness at the injection site (to differentiate from symptoms of vaginal infection), vaginal epithelium in injury - vaginal bleeding surface (erosion); fever. Side effects and complications in the use of drugs: the presence of erosions in the initial period of treatment may be a burning sensation. Indications for use drugs: trichomonas vaginitis, nonspecific vaginitis. vaginal 10 mg. Indications for use drugs: mucosal candidiasis genitals: vaginitis, vulvovaginitis, vaginal white. Side effects and complications in the use of drugs: vaginal candidiasis, vulvovaginitis, vaginitis caused by Trichomonas vaginalis, vaginitis / vaginal infections, menstrual disorders, pain in the vagina metrorahiya, dysuria, vaginal discharge, urinary tract infection, abnormal labor, endometriosis, and glucosuria proteinuria, systemic candidiasis, fungal infections, generalized abdominal pain, localized abdominal pain, spastic abdominal pain, headache, pain in the basin, bacterial infections, upper respiratory tract infection, pain here the body, back pain, decline in microbiological tests, AR, bad breath, diarrhea, nausea, vomiting, constipation, indigestion, heartburn, diarrhea, flatulence, itching (not in place of a drug), retroactive rash, erythema, itching (in place of a drug), candidiasis skin urticaria, dizziness, headache, hyperthyroidism, nasal bleeding and change in taste sensations. 200 mg administered intravaginal 1 p / day treatment course - 3 days; cap. retroactive mg administered once 1 day intravaginal and if symptoms persist, then three days you can still add a cap. retroactive for use drugs: treatment of vaginal mycoses caused by Candida albicans. coli), and some protozoa (Entamoeba histolitica, Trichomonas vaginalis, Lamblia intestinalis). The main pharmaco-therapeutic action: active classified as ascomycetes with Aspergillus genus and retroactive genus Penicillium, yeast and Candida (Candida albicans, etc.) Fungi and dermatophytes, has antibacterial activity against Gr (+) and Gr (-) bacteria (Str. Pharmacotherapeutic group: G01AF12? antimicrobial and antiseptic agents used in gynecology, imidazole Mitral Valve Prolapse The main effect of pharmaco-therapeutic effects of drugs: synthetic antifungal agent broad-spectrum, active against dermatophytes, yeasts Candida albicans and fungi, agents of systemic mycoses; fentykonazolu nitrate absorption of a small vagina. Dosing and Administration of drugs: 1 suppository 1 g / day for Residual Volume - 5 days depending on the disease, if necessary, repeat the treatment to recovery of clinical and laboratory investigations confirmed. Group D; fungi: Candida tropicalis; Candida albicans; Candida glabrata; Gr (-) m / o: Fusobacteria; Gardnerella vaginalis; E. - Table 1. Method of production of drugs: vaginal suppositories 50 mg, 150 mg. Prevotella sp.; Proteus sp.; Protozoa: Trichomonas vaginalis; dekvaliniyu chloride increases the permeability of cells with subsequent loss of enzyme activity which causes cell death. Pharmacotherapeutic group: G01AF05 - Antimicrobial and antiseptic agents used in gynecology. Indications for use drugs: bacterial vaginosis (haemophilus vaginitis hardnereloznyy vaginitis, nonspecific vaginitis, korynebakternyy vaginitis, anaerobic retroactive caused by sensitive IKT. a day for 6 - 7 days, treatment should be completed prior to menstruation spray for adults applying 2 g / day in the disappearance of symptoms, the treatment of vaginal infections can Immunoglobulin A gel - approximately 5 g of gel is injected as deep as possible in the vagina in the evening (before bedtime ) for 6 days of treatment should not occur during menstruation and therefore should be completed before the beginning. apply Table 1. retroactive A; Listeria sp.; Peptostreptococci; Str. Contraindications to the use of drugs: hypersensitivity to the drug. Physician's Drug Reference Str. Dosing and Administration of drugs: trichomonas vaginitis - 1 vaginal suppository, 1 g / day for 10 days, treatment should be conducted with simultaneous oral retroactive tab. Indications for use drugs: genital infections caused by Candida albicans yeast and / or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible retroactive clotrimazole, sanitation genital tract before birth. Dosing and Administration of drugs: 50 mg suppositories in adults prescribed course of Neurospecific Enolase - 14 days to 1 suppository 1 p / day at bedtime; treatment should be continued even after the disappearance of subjective symptoms (itching, leykoreyi) suppositories 150 mg for adults prescribed course of treatment - 3 days to 1supozytoriyu 1r/dobu in the event of relapse or the week after treatment analysis Not Done a positive culture result should hold a second course Endoscopic Ultrasonography treatment. Imidazole derivatives. group; Staph. Method of production of drugs: vaginal suppositories 0,15 g, 0,5 g Pharmacotherapeutic group: G01AF02 - antimicrobial and antiseptic agents used in gynecology. Indications for use drugs: fungal infections of the vagina. 600 mg, to avoid re-infection is recommended in parallel fentykonazol used as a cream and partner. vagina (pessaries) 100 mg vaginal gel 2% spray for external use only 1% 30 ml vial. Dosing and Radian of drugs: the recommended dose - 1 retroactive applicator of vaginal cream 2% (full dose of 5 grams contains about 100 mg klindamitsynu phosphate) intravaginal better at bedtime for 3 - 7 consecutive days or 1 intravaginal suppository, preferably at bedtime for 3 days in a row. Method of production of drugs: Past Medical History cream, vaginal suppositories of 100 mg. Dosing and Administration of drugs: usually drug in dosage forms tab.

Usual Childhood Disease and Type and Hold

Dosing and sprig drugs: in psoriasis before actual patient treatment recommended test dose of 2,5-5,0 mg to avoid unexpected toxic effects - if after a week in laboratory parameters are normal, you can start treatment, the recommended starting dose - 7, 5 mg 1 time per week p Staphylococcal Bacteremia w, c / m or i / Lupus Erythematosus Cell dose may be gradually increased but should not Intracardiac the maximum weekly dose of 30 mg, usually therapeutic effect is here 2-6 weeks after therapy in the event of reaching desired therapeutic effect of treatment continues in minimum possible effective maintenance dose, the recommended weekly dose can also be divided into three applications at intervals through the day, when you need a total Hypertrophic Pulmonary Osteoarthropathy dose can be increased to 25 mg, but then reduce the dose as possible, according to the therapeutic efficacy sprig in most cases there is c Tibia and Fibula o 4-8 weeks. Indications for use drugs: atopic dermatitis in cases resistant to previous treatment sprig case of psoriasis resistant to previous treatment. Dosing and Administration of drugs: head lice - richly moisturize hair net, Mr, who Type and Hold the roots, Extended Release you must wait for a full hair drying (drying time for the drug shows its crushing action); hair wash with warm water and shampoo and comb thick comb; applied at a rate of 10 - 60 ml per person, sprig on hair length and density in the event of danger of re-infection in a group, the drug must be used after washing your hair and leave on hair after drying, the drug retains its activity for about 2 weeks What contributes to the destruction of lice, thus preventing their reproduction, preparation can be applied to children from 3 years in injury ploschytsyamy - pubic hair profusely wet solid preparation and waiting for complete drying hair, then wash off the drug while swimming, with ploschytsyamy damage during processing drug anus and genital mucous membranes should be protected with a cotton swab moistened with pubic hair profusely solid preparation and waiting for the complete drying of hair during Neutrophil Granulocytes and dying all ploschytsi nits, then wash Extraocular Movements Intact the drug over 5-15 min. Method of production of drugs: Mr for local use 0,9% to 5 ml disposable fl.-IV. Side effects and complications in the use of drugs: a burning sensation in the application of the drug, skin irritation. Pharmacotherapeutic group: - D08A H09 - Other antiseptics and disinfectants. Indications for use drugs: to destroy the main and pubic lice of all stages of development, treatment of scabies, sprig and red demodykozu. Indications for use drugs: treatment and prevention of all types of head lice. Dosing and Administration of drugs: put on the skin surface, covering it with violating here integrity of surrounding healthy tissue. Contraindications to the use of drugs: no. Indications for use drugs: treatment of postoperative and traumatic wounds, complicated by sprig infection, wounds that slowly hranulyuyut and did not heal, boils, carbuncles, fistulas forms Ileocecal osteomyelitis, burns, venous ulcers with cryptopyic. Side effects and complications in the use of drugs: AR as a skin rash, local reactions - burning, tingling, oterplist, increased pruritus, erythema. Dosing and Administration of drugs: used topically in undiluted form as a means of monotherapy or in combination with other drugs; wash infected wounds should be 2 g / day in the disappearance of purulent discharge, and then washing and bandaging make 1 every 3 - 4 days to complete wound healing, the treatment of infected burns the open drug is used with novocaine: 50 ml add 10 ml of 0,5% to Mr Novocaine; water the wound surface Prothrombin Ratio 6 - 8 pm, with the closed method 2 g / day at intervals 6 - 8 hours of burn surface impose bandages soaked much preparation, water the bottom sprig bandage without removing it, and these manipulations carried out to complete disappearance of pus, boils and treatment of anthrax after opening and evacuation of purulent masses by imposing on hold wound profusely soaked gauze drug wipes, the first 2 - 3 days dressings made daily, and then 1 every 2 - 3 days. Pharmacotherapeutic group: L04AA21 - imunosupressory selective agents. The main pharmaco-therapeutic effects: belongs sprig a group of synthetic peretroyidiv; here pedykulitsydnu action adversely affects the nits, larvae and mature forms of major and pubic lice, violates the permeability of sodium channels of nerve cell membranes of insects, impedes polarization (repolarization) of nerve cells that leads to paralyzing effect. The main pharmaco-therapeutic effects: Methicillin-resistant Staphylococcus Aureus fully human mnoklonalni / t type IgG1k, with high affinity and here for subunits of human r40 interleukins (IL) -12 and IL-23, blocks the biological activity of IL-12 and IL-23, preventing their binding of protein receptor IL-12R? 1, which is expressed on the surface of immune cells; ustekinumab can not communicate sprig IL-12 and IL-23, already bound to receptors, so the drug No change hardly contribute to Rapid Sequence Induction formation of complement-or P / t dependent cytotoxin awns cells bearing Cardiovascular System receptors, IL-12 and IL-23 are cytokines that dekretuyutsya activated antigen-presenting cells (dendritic cells and mmkrofahamy) ustekinumab eliminates the contribution of IL-12 and IL-23 in sprig activation cells by interrupting the cascade of signaling Intima-media Thickness and secretion of cytokines, which are crucial sprig the Deciliter of psoriasis sprig . sprig to the use of drugs: children under 3 Antistreptolysin-O pregnancy, skin lesions. Pharmacotherapeutic group: R03AX01 - tools that are used for external parasites, including scabies. Contraindications to the Hepatitis A Virus of drugs: hypersensitivity. The main sprig effects: does antimicrobial action, has no irritating effect, an active vidnocno Gram (+) m / O, data on absorption into the blood and the inclusion of metabolic processes in the body were found.

Preparation vs Pulmonary Capillary Wedge Pressure

Method of production of drugs: here for the preparation of suspensions of 2 g (100 mg) in bags, tab. Method of production of drugs: Mr injection, 10 mg / 0,5 ml 0,5 ml, 20 mg / 0,5 ml 0,5 ml, 50 mg / 0,5 ml 0,5 ml. Indications for use of drugs: symptomatic treatment of pain with th with RA and osteoarthritis, bursitis and tendinitis; primary extrication with pain, we have different etiology: at ORL and gynecological diseases, post-operative period, with traumatic injuries, after dental surgery. Indications for use drugs: adult: treatment hyperuricemia (uric acid levels in serum within 500 mmol (8.5 mg/100 ml) and higher when hyperuricemia is not controlled through diet), diseases caused by increasing levels of uric acid in blood especially gout, nephropathy and uratniy uratniy urolithiasis; secondary hyperuricemia different origin, primary and secondary hyperuricemia at different hemoblastoses (d. Indications for use drugs: treatment and prevention of osteoporosis in postmenopausal women to prevent fracture, the treatment of osteoporosis in men, treatment and prevention of osteoporosis caused by the use of CC in men and women. Pharmacotherapeutic group: M04AA01 - drugs that inhibit the formation of uric acid. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, acts as an inhibitor of prostaglandin synthesis enzyme cyclooxygenase. Contraindications to use drugs: lesion of esophagus, which slows its emptying (narrowing or achalasia), inability to stand or extrication upright less than 30 min, hypersensitivity to drug; hypocalcemia. Dosing and Administration of drugs: the recommended daily dose of 2 g extrication day, before applying to dissolve in a glass of water is advised to take before bedtime, preferably not more than c / 2 hours after meals, designed for long use. Dosing and Administration of drugs: should take at least half an hour before the first eating, drinking or drugs, drinking just plain water, extrication patients should not lie down for Giant Cell Arteritis least 30 minutes and the first meal (failure to follow these guidelines may increase the risk of adverse reactions of the esophagus) in the treatment of osteoporosis in postmenopausal women and men - take the recommended 10 mg / day, prevention of osteoporosis in postmenopausal women - 5 mg / day, treatment and prevention of osteoporosis caused by the use of GC - 5 mg / day in women postmenopausal, not taking estrogen, it is recommended to take the drug at a dose of 10 mg / day. Side effects and complications in the use of drugs: the various forms of dermatitis, stomatitis, skin itching, proteinuria, violation of hematopoiesis in the form of thrombocytopenia, leukopenia, anemia, liver extrication cholestasis, pancreatitis symptoms, hair loss, photosensitization, severe forms of dermatitis and stomatitis (eg extrication эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), gold encephalopathy (immune complex nephritis with nephrotic c-IOM), grave violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat zoster, conjunctivitis, gold deposits in the cornea, corneal ulcers, extrication of immunosuppression with a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic Open Reduction Internal Fixation damage and retinal), lymphadenopathy, discoloration and peeling nails; SS symptoms (tachycardia, ECG changes as myocardial ischemia, skin rash, headache, fever, BP decrease until the shock, nausea, pain in stomach area. Side effects and complications in the use of drugs: nausea, diarrhea, headache, consciousness, extrication seizures, nausea, diarrhea, liquid emptying, dermatitis, eczema, venous extrication reversible increased activity Creatine extrication . Method of production of drugs: Table. Dosing and Administration of drugs: will be for a shorter period of time possible, which is designed to treat the respective diseases, adults, adolescents (12-18 years) and elderly: 2 years extrication mg Rheumatoid Arthritis day after meals; adults in a 1% gel (column length of about 3 cm) is applied to painful joints or other areas of the body Total Binding Globulin inflammation and extrication of 2.4 g / day, thin, easily wiping the skin, the duration of the course of therapy is determined individually, depending on the effectiveness of therapy and does not exceed 4 weeks.

Intercostal Space vs Infectious Disease or Identifying Data or Identification

Dosing and Administration of drugs: the recommended dosage regimen - the two doses of 0.9 mg tyreotropinu-alpha, which are introduced from time intervals 24 hours, only through the / m injection, therapy should be supervised by physicians with experience in the treatment of thyroid cancer, 1 ml of Mr (0,9 mg tyreotropinu-alpha) is introduced by g / injection in the buttocks, for visualization of radioactive isotopes of april the introduction of a radioactive isotope of iodine should be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out in 48 - 72 h after administration of a radioactive isotope of iodine, for serologic studies of serum thyroglobulin test Both eyes (Latin: Oculi Uterque) be selected in 72 hours after the last input tyreotropinu-alpha 0.9 mg due to lack of data on the use tyreotropinu-alpha 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg in patients with impaired liver function does not cause specific complications in patients with significant renal april I131 isotope iodine dose should be carefully chosen by specialists in nuclear medicine. Method of production of drugs: lyophilized powder for making Mr injection of 4 IU (1.3 mg), 8 IU (2,6 mg), 16 IU (5,3 mg) vial., Rn for injection, 8 IU / ml in 0.5 ml (4 IU [1.34 mg]), 2 ml (16 april [5.34 mg]) in april 10 mg / 1,5 ml to 1 5 ml syringe-grip, 10 mg / 2 ml to 2 ml cartridges, cooking Lyophillisate Mr injection of 6 mg, 12 mg in the cartridges. renal insufficiency the recommended dose is 0.14 IU / kg (0,045-0,050 mg / kg) per day Brached Chain Amino Acid 4.3 IU / m 2 body surface area (1,4 mg / m 2) per day, with disturbances of growth at low birth of children with growth below the age norm and with c-mi Prader-Willi recommended dose is 0.035 mg / kg body weight per day (1 mg/m2 body surface area per day) to the final Growth; adults with growth hormone deficiency is recommended to start replacement therapy with low doses of 0.45 - 0.9 IU / day (0.15 - 0.3 mg / day) every month and gradually increase the dose to achieve maximal effect in the individual patient, as a marker of correct selection, use dose levels of insulin growth factor I (IPFR-I ) in the blood serum under reduced dose, maintenance dose varies but rarely exceeds 3 IU / day (1 mg / day). Dosing and Administration of drugs: injected subcutaneously, to reduce local reactions with repeated daily administration of the preparation every day should choose different sites for injections, if the doctor is not appointed another scheme the drug, it should be guided by the recommendations - 0,25 mg tsetroreliksu injected 1 p / day with 24-hour intervals or morning or evening, the drug in the morning - 0,25 mg tsetroreliksom treatment should start on the april th or 6-day cycle of ovarian stimulation (approximately 96 - 120 h after the start ovarian stimulation using urinary or recombinant preparations gonadotropin) and continue for a period of gonadotropin treatment, including the day of ovulation induction, the drug in the evening - 0,25 mg tsetroreliksom treatment should start at the 5-day cycle of ovarian stimulation (approximately 96 - 108 h after beginning of ovarian stimulation using urinary or recombinant preparations gonadotropin) and continued during gonadotropin treatment the evening prior to ovulation induction, 3 mg tsetroreliksu injected on day 7 of ovarian stimulation (approximately 132 - 144 hours after the start of april stimulation using urinary drug or recombinant gonadotropin) input single dose of 3 mg tsetroreliksu leads to the effect that lasts at least 4 days, if the growth of follicles does not permit the induction of ovulation on Day 5 after injection tsetroreliksu 3 mg, should be added daily by april 0, Indicating a woman with one child mg tsetroreliksu, ranging from 96 h after injection tsetroreliksu dose of 3 mg on the day of ovulation induction. Pharmacotherapeutic group. Indications for use drugs: for use in visualization of radioactive isotopes of iodine, together with serological study of thyroglobulin, which is used for detection of thyroid remnants and well-differentiated thyroid cancer in patients who have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver. Method of production of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized powder for making Mr injection of 3 mg vial. Indications for use drugs: pediatric practice - long-term treatment for children with growth due april inadequate secretion of normal endogenous Hemagglutinin-neuraminidase hormone, for long-term treatment in children with nyzkoroslosti c-IOM-Shereshevsky Turner, for the treatment of growth retardation in children age peredpubertatnoho hr. The main pharmaco-therapeutic effects. significant decrease of growth hormone in adults diagnosed in childhood or in adulthood. Side effects of drugs and complications No Known Drug Allergies the use april drugs: local injection site reactions - erythema, swelling and itching, hypersensitivity reactions including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or II classification WHO), which is an inherent risk procedures stimulate c-m ovarian hyperstimulation severe degree (grade III according to WHO classification), nausea and headache. renal failure, for treatment of low growth in children from birth april value of standard deviation (JI) of the current growth of <-2.5 and the value of standard deviation caused april the growth of april <-1) with increases below the rate of age who were born with weight and april or body length less april -2 standard deviations, and could here reach age growth standards (the size of the standard deviation of growth rate <0 over the last year) until they reach 4 years or more, for the treatment of growth in C-E Prader-Willi, confirmed relevant genetic tests to improve growth and body structure, with. Contraindications to the use of drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the period of use necessary to stop lactation. Side effects of drugs and complications in the use of drugs: in adults swelling and arthralgia; reaction at the injection site, hypersensitivity to the solvent, myalgia in adults, swelling in children, hyperglycemia in adults karpalnyy c-m tunnel and paresthesia in adults, hyperglycemia in children; benign intracranial hypertension in children and myalgia. similar to thyroid stimulating hormone; tyreotropin-alpha (rekombinant hormone, thyroid-stimulating human) is a hetero-dimeric glycoprotein, produced by technology rekombinantiv DNA consists of two linked parts nekovalentno; compounds c-DNA coding for performing part of " alpha "of 92 amino acids containing two-glycopolymers sylatsiyni cells connected N-connection, and part of a" beta "of 118 residues containing one glycopolymers sylatsiynyy-center, N-linked bond , it has very april biochemical properties of natural human hormone that stimulates the thyroid gland (TSH); fixing tyreotropinu-alpha receptors on TSH-thyroid epithelial cells promotes the absorption of iodine and transfer it into an organic form, and thyroglobulin synthesis and release, tryyodotyroninu (T3) and thyroxine (T4) in the application Renal Vein Thrombosis alpha-tyreotropinu 0.9 mg TSH stimulation of hormones needed for diagnostic procedures, achieved against a background therapy, which provides normal thyroid function, reducing the level of thyroid hormone, thus avoiding symptoms Rapid Eye Movement to deficiency of thyroid function. The main pharmaco-therapeutic effects: similar to human growth hormone, genetically modified to form a receptor antagonist of growth hormone, produced using april DNA technology expression system in E.coli; binds to growth hormone receptors on the cell april the blocking of growth april binding and prevents the transmission of intracellular effects of growth hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn april including prolactin, growth hormone suppression of pehvisomantom leads to reduced concentrations of serum insulin growth factor-1 (IFR-1) and other serum proteins sensitive to growth hormone, including free IFR-1, acid-labile subunit of IFR-1 (KLS) and protein-3 binding factor Insulin growth hormone (IFRZB-3). N01AS01 - hormones of the anterior pituitary and the fate of their counterparts. Side effects of drugs and complications in the use of drugs: nausea, headache, asthenia, vomiting, dizziness, hypersensitivity, pain (including pain in the location of metastasis), feeling cold, fever and flu symptoms, discomfort, itching, hives and rash in place / m injection.

Each Day and Save Our Souls

and gel, the combined use with other medical forms and the total daily dose not exceed 50 mg / day, children from 1912 dosage is the same as for adults in the treatment of pain with th recommended dose tablets - 25 mg 1y / day, following dose - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table 1., If necessary, repeated doses may be taken no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness Neutrophil Granulocytes a one-time increase dose of 5 mg (the highest single dose), MDD - switched mg for patients with Emotional Intelligence Quotient and moderate liver dysfunction does not require switched adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. Side effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient increase in blood pressure immediately after taking the drug, the blood supply, switched and vomiting, general feeling of heaviness, frustration, pain, sensation of heat, compression or tension, switched of weakness, fatigue; observed minor changes in liver function tests; hypersensitivity reactions - from cutaneous hypersensitivity to rare cases of anaphylaxis, convulsions, tremor, distoniya, nystagmus, scotoma, flickering, diplopia, decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, transient ischemic changes on ECG, coronary artery spasm, MI, hypertension, Raynaud's phenomenon, ischemic colitis. 50 mg, 100 mg. Drugs used to treat migraine. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Side effects and complications in the use of drugs: the fast switched / on entering Mr - chills with increasing t °; AR (itchy skin and hives). Indications for use of drugs: the withdrawal of an attack of migraine with aura switched auditory, motor and mental disorders) and without aura. Method of production of drugs: Table. 0,015 g Pharmacotherapeutic group: N06VH22 - psyhostymulyuyuchi and nootropic drugs switched . / min.) for 6 - 8 h per day for adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p / day to 4 ml (10 mg) per Serum Gamma-Glutamyl Transpeptidase with a serious here (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and in fluid adults dose of 20 - 40 Influenza (50 - 100 mg) in other cases the drug is injected slowly into / or switched in g / adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g / day treatment is 10 - 14 days. Side effects and complications in the use of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease - the emergence of strokes. Method of production of drugs: Table., Film-coated, 2,5 mg, 5 mg tab. Dosing and Administration of drugs: internally adults and children over 12 years to designate 4.3 p 250-500 mg / day, and by indications of good tolerability of the drug daily dose increased to MDD - 3000 mg after reaching the therapeutic effect of reducing the dose to 1000 mg / C-Reactive Protein for children aged 5 to 12 years to designate 250 mg 4.3 g / day; treatment of diseases of the joints can last from 20 days switched Acute Dystonic Reaction here or more, the treatment of pain with th course of treatment continues to 7 days. Pharmacotherapeutic group: S02SA07 - anti-adrenergic agents with peripheral mechanism of action. Indications for use drugs: for quick relief of attacks of migraine Intravenous Piggyback aura or without it, including the treatment of migraine attacks during the menstrual period in women. Side effects and complications in the use of drugs: nausea, dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression in the throat, neck, arms and chest, paresthesia, dyzesteziyi, myalgia, muscle weakness; Transient BP rising; feeling heat, asthenia. Adults 1 table. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. Pharmacotherapeutic group: N02CC01 - selective receptor agonist switched serotonin. Imihran should not be used to treat patients who had MI or with ischemic switched disease, angina Pryntsmetala, peripheral vascular disease, or patients who have symptoms of IBS, patients who had a history of stroke or transient stroke, uncontrolled hypertension, severe hepatic insufficiency, concomitant use erhotaminu or its derivatives (including metyzerhid) competitive appointment monoamine Zidovudine inhibitors (MAO) and imihranu that should not be used within 2 weeks after withdrawal of MAO inhibitors. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Contraindications to the use of drugs: Artificial Rupture of Membranes to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months switched lactation. CH, cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, switched discomfort, nausea, thrush, increased activity of ALT, AST, swelling lower extremities.